| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 45 | 2023 | 161 | 14.460 |
Why?
|
| Hepatitis, Alcoholic | 31 | 2023 | 103 | 13.630 |
Why?
|
| Ethanol | 67 | 2023 | 1342 | 11.840 |
Why?
|
| Inflammasomes | 21 | 2023 | 494 | 6.100 |
Why?
|
| Fatty Liver, Alcoholic | 18 | 2020 | 40 | 5.750 |
Why?
|
| MicroRNAs | 36 | 2021 | 3747 | 5.220 |
Why?
|
| Hepacivirus | 31 | 2017 | 1379 | 5.120 |
Why?
|
| Hepatocytes | 28 | 2022 | 1210 | 4.740 |
Why?
|
| Fatty Liver | 18 | 2022 | 729 | 4.270 |
Why?
|
| Liver | 52 | 2023 | 7472 | 3.890 |
Why?
|
| Toll-Like Receptor 4 | 27 | 2017 | 567 | 3.730 |
Why?
|
| Liver Diseases | 18 | 2021 | 1254 | 3.580 |
Why?
|
| Monocytes | 30 | 2019 | 2594 | 3.540 |
Why?
|
| Exosomes | 10 | 2021 | 413 | 3.340 |
Why?
|
| Hepatitis | 10 | 2023 | 227 | 3.250 |
Why?
|
| Hepatitis C, Chronic | 21 | 2017 | 1031 | 3.020 |
Why?
|
| Hepatitis C | 22 | 2015 | 1591 | 2.560 |
Why?
|
| Macrophages | 21 | 2022 | 5657 | 2.550 |
Why?
|
| Lipopolysaccharides | 33 | 2022 | 2216 | 2.490 |
Why?
|
| Liver Cirrhosis | 14 | 2023 | 1864 | 2.180 |
Why?
|
| Alcohol Drinking | 22 | 2021 | 3966 | 2.150 |
Why?
|
| Inflammation | 39 | 2023 | 10634 | 2.100 |
Why?
|
| Central Nervous System Depressants | 8 | 2018 | 167 | 2.090 |
Why?
|
| Dendritic Cells | 20 | 2013 | 2725 | 2.050 |
Why?
|
| Immunity, Innate | 19 | 2015 | 2958 | 1.880 |
Why?
|
| Toll-Like Receptors | 13 | 2013 | 592 | 1.860 |
Why?
|
| End Stage Liver Disease | 6 | 2023 | 314 | 1.810 |
Why?
|
| Alcoholism | 17 | 2023 | 1906 | 1.740 |
Why?
|
| Kupffer Cells | 13 | 2019 | 142 | 1.710 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 6 | 2022 | 297 | 1.650 |
Why?
|
| Toll-Like Receptor 2 | 15 | 2010 | 354 | 1.620 |
Why?
|
| Mice, Inbred C57BL | 48 | 2023 | 21824 | 1.610 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2023 | 123 | 1.570 |
Why?
|
| Macrophage Activation | 8 | 2019 | 558 | 1.540 |
Why?
|
| Viral Core Proteins | 8 | 2008 | 162 | 1.540 |
Why?
|
| Carcinoma, Hepatocellular | 11 | 2018 | 2214 | 1.450 |
Why?
|
| Receptors, CCR2 | 3 | 2020 | 212 | 1.430 |
Why?
|
| Neutrophil Infiltration | 4 | 2021 | 390 | 1.390 |
Why?
|
| Interferon-alpha | 10 | 2013 | 895 | 1.390 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2023 | 627 | 1.380 |
Why?
|
| Animals | 123 | 2023 | 168788 | 1.370 |
Why?
|
| Signal Transduction | 33 | 2021 | 23404 | 1.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 25 | 2016 | 4419 | 1.360 |
Why?
|
| NF-kappa B | 18 | 2022 | 2501 | 1.350 |
Why?
|
| Liver Cirrhosis, Alcoholic | 6 | 2023 | 65 | 1.350 |
Why?
|
| Inflammation Mediators | 12 | 2020 | 1889 | 1.350 |
Why?
|
| Liver Neoplasms | 14 | 2018 | 4252 | 1.340 |
Why?
|
| Cytokines | 29 | 2020 | 7326 | 1.270 |
Why?
|
| Interleukin-1beta | 12 | 2023 | 972 | 1.230 |
Why?
|
| Mice | 70 | 2023 | 81178 | 1.220 |
Why?
|
| Endotoxins | 5 | 2016 | 527 | 1.180 |
Why?
|
| Immune System | 6 | 2015 | 805 | 1.180 |
Why?
|
| Interleukin-10 | 9 | 2015 | 1200 | 1.140 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2016 | 191 | 1.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 5 | 2014 | 571 | 1.090 |
Why?
|
| Interleukin-1 | 5 | 2017 | 1263 | 1.090 |
Why?
|
| Interferon Type I | 5 | 2013 | 542 | 1.040 |
Why?
|
| Myeloid Cells | 6 | 2012 | 809 | 1.040 |
Why?
|
| Acetaminophen | 6 | 2017 | 545 | 1.040 |
Why?
|
| Oxazines | 2 | 2016 | 298 | 0.990 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2007 | 241 | 0.980 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2018 | 434 | 0.970 |
Why?
|
| Carrier Proteins | 8 | 2019 | 5021 | 0.940 |
Why?
|
| RNA, Viral | 6 | 2021 | 2902 | 0.920 |
Why?
|
| Liver Cirrhosis, Experimental | 2 | 2016 | 32 | 0.920 |
Why?
|
| Caspase 1 | 5 | 2023 | 224 | 0.910 |
Why?
|
| Liver Regeneration | 2 | 2017 | 210 | 0.900 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2023 | 97 | 0.880 |
Why?
|
| Choline Deficiency | 6 | 2014 | 28 | 0.860 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2017 | 172 | 0.860 |
Why?
|
| Interferon-gamma | 8 | 2016 | 3203 | 0.850 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2014 | 198 | 0.840 |
Why?
|
| Pentoxifylline | 1 | 2022 | 55 | 0.840 |
Why?
|
| Virus Replication | 8 | 2015 | 2534 | 0.840 |
Why?
|
| Gene Expression Regulation | 11 | 2021 | 12075 | 0.830 |
Why?
|
| Cholestasis | 3 | 2023 | 378 | 0.820 |
Why?
|
| Up-Regulation | 12 | 2016 | 4217 | 0.810 |
Why?
|
| Methionine | 7 | 2015 | 590 | 0.810 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 159 | 0.810 |
Why?
|
| Interleukin-13 | 1 | 2023 | 389 | 0.800 |
Why?
|
| Hepatitis, Chronic | 1 | 2021 | 52 | 0.800 |
Why?
|
| Mice, Knockout | 22 | 2022 | 14556 | 0.790 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1888 | 0.790 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 220 | 0.790 |
Why?
|
| Autophagy | 2 | 2019 | 1300 | 0.770 |
Why?
|
| Membrane Glycoproteins | 5 | 2019 | 3769 | 0.760 |
Why?
|
| Alcohols | 2 | 2014 | 92 | 0.760 |
Why?
|
| Cell Communication | 7 | 2021 | 1621 | 0.750 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2015 | 1836 | 0.740 |
Why?
|
| Acute-Phase Proteins | 2 | 2019 | 262 | 0.730 |
Why?
|
| Gastroenterology | 2 | 2021 | 536 | 0.730 |
Why?
|
| Humans | 173 | 2023 | 744220 | 0.720 |
Why?
|
| Immunity | 3 | 2020 | 1012 | 0.700 |
Why?
|
| Alanine Transaminase | 7 | 2016 | 592 | 0.690 |
Why?
|
| Disease Progression | 14 | 2021 | 13280 | 0.690 |
Why?
|
| Uric Acid | 2 | 2015 | 765 | 0.690 |
Why?
|
| Microglia | 2 | 2020 | 1266 | 0.670 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2017 | 90 | 0.660 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2025 | 0.660 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2016 | 107 | 0.650 |
Why?
|
| Chemokine CCL2 | 7 | 2016 | 617 | 0.650 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 497 | 0.640 |
Why?
|
| Toll-Like Receptor 9 | 4 | 2014 | 212 | 0.620 |
Why?
|
| Membrane Microdomains | 3 | 2013 | 203 | 0.620 |
Why?
|
| CARD Signaling Adaptor Proteins | 4 | 2023 | 156 | 0.610 |
Why?
|
| Disease Models, Animal | 22 | 2021 | 18027 | 0.610 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 390 | 0.610 |
Why?
|
| Cytoskeletal Proteins | 2 | 2013 | 1364 | 0.600 |
Why?
|
| Research | 4 | 2021 | 1999 | 0.590 |
Why?
|
| Vimentin | 2 | 2015 | 261 | 0.580 |
Why?
|
| Killer Cells, Natural | 6 | 2015 | 2133 | 0.570 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2867 | 0.560 |
Why?
|
| Female | 83 | 2023 | 380197 | 0.550 |
Why?
|
| Lymphocyte Antigen 96 | 3 | 2011 | 19 | 0.540 |
Why?
|
| Hepatitis C Antibodies | 2 | 2012 | 145 | 0.540 |
Why?
|
| Probenecid | 1 | 2015 | 76 | 0.530 |
Why?
|
| Blotting, Western | 9 | 2017 | 5180 | 0.520 |
Why?
|
| Phagocytosis | 2 | 2018 | 1538 | 0.520 |
Why?
|
| Granuloma | 2 | 2008 | 317 | 0.510 |
Why?
|
| Reactive Oxygen Species | 6 | 2022 | 2078 | 0.510 |
Why?
|
| Sarcopenia | 1 | 2020 | 368 | 0.510 |
Why?
|
| Encephalitis | 1 | 2018 | 423 | 0.510 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2022 | 262 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7879 | 0.490 |
Why?
|
| Pyridines | 2 | 2016 | 2822 | 0.490 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 955 | 0.480 |
Why?
|
| Gastrointestinal Tract | 2 | 2011 | 814 | 0.480 |
Why?
|
| Cell Differentiation | 9 | 2017 | 11478 | 0.480 |
Why?
|
| Cells, Cultured | 16 | 2017 | 19227 | 0.480 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.480 |
Why?
|
| Neutrophils | 3 | 2022 | 3717 | 0.470 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2019 | 388 | 0.470 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2019 | 3871 | 0.470 |
Why?
|
| Allopurinol | 1 | 2015 | 191 | 0.470 |
Why?
|
| RNA, Messenger | 13 | 2022 | 13036 | 0.460 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2013 | 250 | 0.460 |
Why?
|
| Intestines | 4 | 2018 | 1924 | 0.460 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 874 | 0.460 |
Why?
|
| Cell Death | 3 | 2021 | 1708 | 0.460 |
Why?
|
| Neutralization Tests | 2 | 2014 | 758 | 0.460 |
Why?
|
| Cyclin G1 | 1 | 2012 | 17 | 0.450 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 769 | 0.440 |
Why?
|
| Antigen-Presenting Cells | 3 | 2008 | 973 | 0.440 |
Why?
|
| RNA Stability | 2 | 2015 | 322 | 0.440 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2015 | 30 | 0.430 |
Why?
|
| Probiotics | 2 | 2023 | 351 | 0.430 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 729 | 0.420 |
Why?
|
| Apoptosis | 10 | 2023 | 9728 | 0.420 |
Why?
|
| Cell Polarity | 1 | 2015 | 645 | 0.420 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2009 | 78 | 0.410 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2023 | 143 | 0.400 |
Why?
|
| Transcription Factors | 6 | 2017 | 12207 | 0.400 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 9647 | 0.390 |
Why?
|
| Interleukins | 2 | 2012 | 791 | 0.390 |
Why?
|
| Poly I-C | 1 | 2011 | 115 | 0.390 |
Why?
|
| Reperfusion Injury | 2 | 2015 | 1026 | 0.390 |
Why?
|
| Interleukin-12 | 2 | 2004 | 579 | 0.390 |
Why?
|
| Cell Proliferation | 6 | 2022 | 10480 | 0.380 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2010 | 10 | 0.380 |
Why?
|
| Phosphorylation | 8 | 2023 | 8437 | 0.370 |
Why?
|
| Metabolome | 1 | 2017 | 895 | 0.370 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2007 | 48 | 0.370 |
Why?
|
| Brain | 5 | 2020 | 26413 | 0.360 |
Why?
|
| alpha-Fetoproteins | 2 | 2023 | 222 | 0.360 |
Why?
|
| Interleukin-6 | 7 | 2023 | 3201 | 0.350 |
Why?
|
| Case-Control Studies | 11 | 2020 | 21752 | 0.350 |
Why?
|
| RNA, Double-Stranded | 1 | 2011 | 290 | 0.350 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 4 | 2022 | 65 | 0.350 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2014 | 300 | 0.350 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 847 | 0.350 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2586 | 0.340 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 1467 | 0.340 |
Why?
|
| Sepsis | 3 | 2018 | 2593 | 0.330 |
Why?
|
| Propionibacterium acnes | 2 | 2008 | 66 | 0.330 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 393 | 0.330 |
Why?
|
| Male | 50 | 2023 | 350027 | 0.330 |
Why?
|
| Antigens, CD | 1 | 2019 | 4026 | 0.320 |
Why?
|
| Autoantigens | 1 | 2013 | 892 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4752 | 0.320 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 1903 | 0.320 |
Why?
|
| Transcription Factor RelA | 2 | 2007 | 275 | 0.320 |
Why?
|
| Immunity, Cellular | 3 | 2012 | 1607 | 0.320 |
Why?
|
| DNA Virus Infections | 1 | 2008 | 13 | 0.320 |
Why?
|
| RNA Virus Infections | 1 | 2008 | 17 | 0.320 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1152 | 0.310 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2007 | 28 | 0.310 |
Why?
|
| Metagenome | 1 | 2011 | 418 | 0.310 |
Why?
|
| Statistics, Nonparametric | 5 | 2014 | 2886 | 0.300 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 176 | 0.300 |
Why?
|
| Liver Transplantation | 6 | 2021 | 2118 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2012 | 2915 | 0.300 |
Why?
|
| Fibrosis | 3 | 2021 | 2029 | 0.300 |
Why?
|
| Gene Expression | 5 | 2017 | 7799 | 0.300 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 320 | 0.290 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2012 | 2988 | 0.290 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 144 | 0.290 |
Why?
|
| Severity of Illness Index | 9 | 2023 | 15538 | 0.290 |
Why?
|
| Age Factors | 1 | 2023 | 18367 | 0.280 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 697 | 0.280 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3036 | 0.280 |
Why?
|
| Carbon Tetrachloride | 2 | 2016 | 64 | 0.280 |
Why?
|
| Propionibacterium | 1 | 2005 | 4 | 0.280 |
Why?
|
| Bacteria | 4 | 2022 | 2114 | 0.270 |
Why?
|
| Cerebellum | 1 | 2013 | 1490 | 0.270 |
Why?
|
| Science | 1 | 2009 | 241 | 0.270 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 252 | 0.270 |
Why?
|
| CHO Cells | 5 | 2007 | 1407 | 0.270 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 1821 | 0.270 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.270 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2006 | 78 | 0.270 |
Why?
|
| Cell Line | 8 | 2015 | 15999 | 0.270 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 317 | 0.270 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2022 | 107 | 0.260 |
Why?
|
| Oxidative Stress | 6 | 2022 | 3085 | 0.260 |
Why?
|
| Clinical Trials as Topic | 3 | 2019 | 7908 | 0.260 |
Why?
|
| Gene Silencing | 1 | 2012 | 1538 | 0.260 |
Why?
|
| Liver Function Tests | 4 | 2019 | 528 | 0.260 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 225 | 0.260 |
Why?
|
| Interleukin-1alpha | 2 | 2017 | 84 | 0.260 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2513 | 0.260 |
Why?
|
| Research Design | 3 | 2017 | 5987 | 0.260 |
Why?
|
| Immune Tolerance | 2 | 2012 | 2258 | 0.250 |
Why?
|
| Cricetinae | 5 | 2007 | 2472 | 0.250 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1978 | 0.250 |
Why?
|
| Antibody Formation | 2 | 2006 | 1402 | 0.250 |
Why?
|
| T-Lymphocytes | 5 | 2008 | 10182 | 0.250 |
Why?
|
| Receptors, Immunologic | 3 | 2007 | 1423 | 0.250 |
Why?
|
| Triglycerides | 4 | 2014 | 2453 | 0.250 |
Why?
|
| HMGB1 Protein | 2 | 2018 | 133 | 0.250 |
Why?
|
| src-Family Kinases | 1 | 2007 | 551 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2942 | 0.240 |
Why?
|
| Adult | 32 | 2022 | 214035 | 0.240 |
Why?
|
| Isoantigens | 2 | 2004 | 567 | 0.240 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2002 | 302 | 0.240 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4328 | 0.240 |
Why?
|
| Ligands | 5 | 2012 | 3294 | 0.240 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.240 |
Why?
|
| Amino Acids, Aromatic | 1 | 2023 | 32 | 0.240 |
Why?
|
| Down-Regulation | 4 | 2018 | 3001 | 0.240 |
Why?
|
| Middle Aged | 33 | 2022 | 213367 | 0.230 |
Why?
|
| Heme Oxygenase-1 | 1 | 2006 | 381 | 0.230 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 9438 | 0.230 |
Why?
|
| Antigens, Ly | 1 | 2004 | 291 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3703 | 0.230 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2016 | 36 | 0.230 |
Why?
|
| Fatty Acids | 1 | 2011 | 1808 | 0.220 |
Why?
|
| Interferons | 3 | 2012 | 706 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2023 | 2895 | 0.220 |
Why?
|
| Time Factors | 9 | 2018 | 40063 | 0.220 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2005 | 341 | 0.220 |
Why?
|
| Coenzyme A Ligases | 1 | 2022 | 43 | 0.220 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 871 | 0.210 |
Why?
|
| Antiviral Agents | 6 | 2012 | 2987 | 0.210 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 264 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1655 | 0.210 |
Why?
|
| Bile Ducts | 1 | 2023 | 284 | 0.210 |
Why?
|
| Prognosis | 9 | 2021 | 29050 | 0.210 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 385 | 0.210 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 363 | 0.200 |
Why?
|
| Autoimmunity | 1 | 2009 | 1349 | 0.190 |
Why?
|
| Sulfoxides | 1 | 2020 | 48 | 0.190 |
Why?
|
| Methylamines | 1 | 2022 | 123 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 905 | 0.190 |
Why?
|
| Permeability | 2 | 2014 | 738 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 1001 | 0.190 |
Why?
|
| Diet | 4 | 2015 | 7937 | 0.190 |
Why?
|
| Kidney | 4 | 2023 | 7183 | 0.190 |
Why?
|
| Methylprednisolone | 1 | 2022 | 388 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2916 | 0.190 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2010 | 39 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2016 | 625 | 0.180 |
Why?
|
| Antigen Presentation | 2 | 2004 | 1284 | 0.180 |
Why?
|
| ROC Curve | 3 | 2019 | 3527 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 4385 | 0.180 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 644 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 315 | 0.180 |
Why?
|
| Leptin | 2 | 2005 | 1599 | 0.180 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1677 | 0.180 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2012 | 517 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 595 | 0.180 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2019 | 26 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 608 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8426 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4553 | 0.180 |
Why?
|
| Actins | 3 | 2014 | 2121 | 0.170 |
Why?
|
| Cell Line, Tumor | 6 | 2013 | 16687 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 2425 | 0.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 648 | 0.170 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 52 | 0.170 |
Why?
|
| Stress, Physiological | 2 | 2023 | 1404 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1838 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2021 | 9147 | 0.170 |
Why?
|
| Indenes | 1 | 2020 | 57 | 0.170 |
Why?
|
| Response Elements | 2 | 2016 | 311 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2002 | 582 | 0.170 |
Why?
|
| Coculture Techniques | 2 | 2013 | 1341 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1525 | 0.170 |
Why?
|
| Collagen Type I | 2 | 2014 | 592 | 0.160 |
Why?
|
| Polyethylene Glycols | 4 | 2012 | 1181 | 0.160 |
Why?
|
| Protein S | 1 | 2018 | 30 | 0.160 |
Why?
|
| Furans | 1 | 2020 | 194 | 0.160 |
Why?
|
| Viral Proteins | 3 | 2013 | 1900 | 0.160 |
Why?
|
| Cause of Death | 2 | 2019 | 3584 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 154 | 0.160 |
Why?
|
| Mitochondria, Liver | 2 | 2011 | 187 | 0.160 |
Why?
|
| Zinc | 1 | 2022 | 683 | 0.160 |
Why?
|
| Forecasting | 2 | 2022 | 2949 | 0.150 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2011 | 472 | 0.150 |
Why?
|
| Dipeptides | 1 | 2020 | 409 | 0.150 |
Why?
|
| Protein Binding | 4 | 2015 | 9392 | 0.150 |
Why?
|
| Sex Factors | 3 | 2018 | 10396 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2002 | 611 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2022 | 1639 | 0.150 |
Why?
|
| Homeostasis | 2 | 2023 | 3339 | 0.150 |
Why?
|
| Sulfones | 1 | 2020 | 437 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1157 | 0.150 |
Why?
|
| Phenotype | 4 | 2016 | 16365 | 0.140 |
Why?
|
| Diethylnitrosamine | 1 | 2016 | 38 | 0.140 |
Why?
|
| Diethylamines | 1 | 2016 | 3 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2015 | 2969 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2279 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2003 | 1904 | 0.140 |
Why?
|
| Hep G2 Cells | 2 | 2018 | 392 | 0.140 |
Why?
|
| RNA Transport | 1 | 2015 | 48 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 3 | 2015 | 2008 | 0.130 |
Why?
|
| Biopsy | 4 | 2019 | 6757 | 0.130 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2015 | 50 | 0.130 |
Why?
|
| Mitochondria | 2 | 2005 | 3520 | 0.130 |
Why?
|
| Recombinant Proteins | 6 | 2012 | 6612 | 0.130 |
Why?
|
| Fungi | 1 | 2018 | 327 | 0.130 |
Why?
|
| Mannose-Binding Lectins | 1 | 2015 | 100 | 0.130 |
Why?
|
| Cholesterol | 3 | 2021 | 2911 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 103 | 0.130 |
Why?
|
| Antimetabolites | 1 | 2015 | 125 | 0.130 |
Why?
|
| Smad3 Protein | 1 | 2015 | 180 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 16 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2014 | 1477 | 0.120 |
Why?
|
| Th2 Cells | 3 | 2017 | 1061 | 0.120 |
Why?
|
| Cricetulus | 2 | 2007 | 817 | 0.120 |
Why?
|
| PPAR alpha | 1 | 2016 | 196 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4665 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 73 | 0.120 |
Why?
|
| Imidazoles | 1 | 2020 | 1206 | 0.120 |
Why?
|
| Procollagen | 1 | 2014 | 185 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1086 | 0.120 |
Why?
|
| Patient Care Management | 1 | 2017 | 306 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2204 | 0.120 |
Why?
|
| Models, Biological | 4 | 2015 | 9582 | 0.120 |
Why?
|
| Interleukin-18 | 1 | 2015 | 249 | 0.120 |
Why?
|
| Virus Diseases | 2 | 2015 | 711 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 534 | 0.120 |
Why?
|
| Flow Cytometry | 4 | 2012 | 5974 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1372 | 0.110 |
Why?
|
| Choline | 1 | 2015 | 493 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3921 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 11368 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1702 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2015 | 594 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1854 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 713 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5853 | 0.110 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2012 | 30 | 0.110 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3188 | 0.110 |
Why?
|
| Receptors, Interferon | 1 | 2012 | 115 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3505 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 431 | 0.110 |
Why?
|
| Fructose | 1 | 2014 | 288 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 588 | 0.110 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 247 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 1866 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1284 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17449 | 0.100 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 46 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4151 | 0.100 |
Why?
|
| Risk Factors | 8 | 2020 | 72280 | 0.100 |
Why?
|
| Receptors, Virus | 1 | 2014 | 648 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2015 | 2335 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3800 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10949 | 0.090 |
Why?
|
| Activins | 1 | 2012 | 208 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 149 | 0.090 |
Why?
|
| Physicians | 1 | 2009 | 4564 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 1 | 2012 | 418 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6535 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 442 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2021 | 4156 | 0.090 |
Why?
|
| Ribavirin | 1 | 2012 | 395 | 0.090 |
Why?
|
| Thiazoles | 2 | 2011 | 1484 | 0.090 |
Why?
|
| Acetylation | 1 | 2013 | 1085 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2020 | 1940 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2015 | 906 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2015 | 1880 | 0.090 |
Why?
|
| RNA | 2 | 2012 | 2749 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2252 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 350 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 270 | 0.090 |
Why?
|
| Insulin | 2 | 2015 | 6583 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 2108 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2012 | 433 | 0.090 |
Why?
|
| Length of Stay | 3 | 2020 | 6308 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7179 | 0.090 |
Why?
|
| Self Report | 1 | 2020 | 3558 | 0.090 |
Why?
|
| Invertebrates | 1 | 2009 | 50 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2019 | 10250 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1971 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2016 | 1548 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
| United States | 7 | 2020 | 69867 | 0.080 |
Why?
|
| Life Style | 1 | 2020 | 3835 | 0.080 |
Why?
|
| DNA | 2 | 2016 | 7303 | 0.080 |
Why?
|
| Endocytosis | 1 | 2013 | 985 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 261 | 0.080 |
Why?
|
| Hepatitis C Antigens | 1 | 2007 | 34 | 0.080 |
Why?
|
| CpG Islands | 1 | 2012 | 1172 | 0.080 |
Why?
|
| Herbal Medicine | 1 | 2008 | 37 | 0.080 |
Why?
|
| Myocardium | 1 | 2021 | 4776 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2458 | 0.080 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2010 | 207 | 0.080 |
Why?
|
| Vertebrates | 1 | 2009 | 227 | 0.080 |
Why?
|
| DNA Primers | 1 | 2012 | 2892 | 0.080 |
Why?
|
| Molecular Biology | 1 | 2011 | 596 | 0.080 |
Why?
|
| NADP | 1 | 2008 | 226 | 0.080 |
Why?
|
| Microtubules | 1 | 2013 | 1091 | 0.080 |
Why?
|
| Metals | 1 | 2012 | 719 | 0.070 |
Why?
|
| Knowledge | 1 | 2009 | 181 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 1080 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2015 | 2751 | 0.070 |
Why?
|
| Chimera | 1 | 2008 | 485 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2008 | 5523 | 0.070 |
Why?
|
| Dependovirus | 1 | 2012 | 706 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1372 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 644 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2017 | 2925 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 12355 | 0.070 |
Why?
|
| Quinolines | 1 | 2011 | 730 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2007 | 251 | 0.070 |
Why?
|
| Primates | 1 | 2009 | 544 | 0.070 |
Why?
|
| Ketoconazole | 1 | 2006 | 95 | 0.070 |
Why?
|
| Leukopenia | 1 | 2006 | 208 | 0.070 |
Why?
|
| Membrane Fluidity | 1 | 2006 | 73 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2015 | 1401 | 0.070 |
Why?
|
| RNA Interference | 1 | 2015 | 2890 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 879 | 0.070 |
Why?
|
| Behavior | 1 | 2009 | 560 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2218 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2634 | 0.070 |
Why?
|
| Public Health | 1 | 2019 | 2603 | 0.070 |
Why?
|
| Hepatitis B | 1 | 2011 | 695 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 638 | 0.070 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2005 | 67 | 0.070 |
Why?
|
| Disease | 1 | 2011 | 681 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12244 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 452 | 0.060 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 121 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2005 | 2131 | 0.060 |
Why?
|
| Viral Envelope Proteins | 2 | 2012 | 635 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2006 | 364 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 491 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.060 |
Why?
|
| HIV Infections | 1 | 2011 | 16718 | 0.060 |
Why?
|
| Congresses as Topic | 2 | 2020 | 764 | 0.060 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2006 | 315 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 2006 | 249 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14726 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 1155 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2005 | 424 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1294 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 853 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4666 | 0.060 |
Why?
|
| Thrombosis | 1 | 2018 | 2968 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1534 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2455 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2171 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2292 | 0.060 |
Why?
|
| Liver Failure, Acute | 1 | 2005 | 165 | 0.060 |
Why?
|
| Viruses | 1 | 2008 | 374 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2005 | 360 | 0.060 |
Why?
|
| Hydroxylation | 1 | 2023 | 141 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2013 | 6461 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 534 | 0.060 |
Why?
|
| Mammals | 1 | 2009 | 1144 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2011 | 2017 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15070 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6367 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2006 | 553 | 0.050 |
Why?
|
| Coenzyme A | 1 | 2022 | 39 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 56436 | 0.050 |
Why?
|
| Career Choice | 1 | 2009 | 744 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2007 | 1539 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 1873 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 927 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 9852 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2010 | 2739 | 0.050 |
Why?
|
| Collagen | 1 | 2011 | 2689 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 916 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 703 | 0.050 |
Why?
|
| Cell Separation | 1 | 2008 | 1751 | 0.050 |
Why?
|
| Aged | 8 | 2021 | 163253 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1185 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 479 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 458 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2006 | 730 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 165 | 0.050 |
Why?
|
| Complement C2 | 1 | 2020 | 72 | 0.050 |
Why?
|
| Liver Circulation | 1 | 2021 | 163 | 0.050 |
Why?
|
| Complement Factor D | 1 | 2020 | 68 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4442 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2020 | 72 | 0.050 |
Why?
|
| Base Sequence | 1 | 2012 | 12801 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1881 | 0.050 |
Why?
|
| Complement C5 | 1 | 2020 | 112 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23337 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 2732 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 743 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2014 | 3863 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 35423 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3701 | 0.050 |
Why?
|
| Oxygen | 1 | 2012 | 4187 | 0.050 |
Why?
|
| Complement C4 | 1 | 2020 | 257 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2021 | 374 | 0.050 |
Why?
|
| Heart | 2 | 2021 | 4465 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2020 | 63119 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 237 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5529 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2014 | 6259 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2002 | 531 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 694 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 297 | 0.040 |
Why?
|
| Tyrosine | 1 | 2023 | 1461 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6101 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 476 | 0.040 |
Why?
|
| Comorbidity | 2 | 2011 | 10387 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 1812 | 0.040 |
Why?
|
| Nutrition Therapy | 1 | 2020 | 96 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 461 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7148 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 822 | 0.040 |
Why?
|
| Viral Load | 2 | 2021 | 3300 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2008 | 1582 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11732 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 675 | 0.040 |
Why?
|
| Pharmacokinetics | 1 | 1998 | 88 | 0.040 |
Why?
|
| Cell Survival | 2 | 2012 | 5881 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 2021 | 435 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2020 | 795 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1021 | 0.040 |
Why?
|
| Random Allocation | 1 | 2022 | 2427 | 0.040 |
Why?
|
| Cell Movement | 2 | 2008 | 5216 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5257 | 0.040 |
Why?
|
| Adolescent | 5 | 2010 | 85759 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20123 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1420 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 610 | 0.040 |
Why?
|
| Levodopa | 1 | 1997 | 219 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2021 | 878 | 0.040 |
Why?
|
| Public Opinion | 1 | 2020 | 477 | 0.040 |
Why?
|
| Transfection | 1 | 2004 | 5892 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15161 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 12956 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15294 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2021 | 2007 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 712 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4567 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 2848 | 0.030 |
Why?
|
| Attitude | 1 | 2020 | 774 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9275 | 0.030 |
Why?
|
| North America | 1 | 2018 | 1250 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2002 | 1948 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2010 | 3311 | 0.030 |
Why?
|
| Feces | 2 | 2017 | 1402 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12961 | 0.030 |
Why?
|
| Pneumonia | 1 | 2006 | 2134 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1914 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2020 | 867 | 0.030 |
Why?
|
| Asthma | 1 | 2012 | 6011 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2016 | 601 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 1147 | 0.030 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2011 | 9 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2002 | 4199 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2012 | 229 | 0.030 |
Why?
|
| Europe | 1 | 2018 | 3339 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2011 | 86 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 77426 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2021 | 3748 | 0.020 |
Why?
|
| Th1 Cells | 2 | 2006 | 1057 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4396 | 0.020 |
Why?
|
| Obesity | 2 | 2020 | 12742 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 2875 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8321 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 1998 | 1071 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2006 | 3444 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3690 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3478 | 0.020 |
Why?
|
| Silymarin | 1 | 2008 | 40 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 469 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8343 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 2958 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 1962 | 0.020 |
Why?
|
| Digestive System Neoplasms | 1 | 2006 | 87 | 0.020 |
Why?
|
| APACHE | 1 | 2006 | 277 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2018 | 4399 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2006 | 40559 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2776 | 0.010 |
Why?
|
| Metabolomics | 1 | 2011 | 1483 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2021 | 53280 | 0.010 |
Why?
|
| Chromans | 1 | 2002 | 122 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6172 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12718 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12264 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6485 | 0.010 |
Why?
|
| Morphine | 1 | 2006 | 657 | 0.010 |
Why?
|
| Transaminases | 1 | 2002 | 199 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2539 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13817 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 865 | 0.010 |
Why?
|
| Proteomics | 1 | 2011 | 3637 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2010 | 2062 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1998 | 84 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2006 | 1826 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1997 | 75 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1998 | 469 | 0.010 |
Why?
|
| Logistic Models | 1 | 2012 | 13409 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 12805 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57768 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2006 | 1885 | 0.010 |
Why?
|
| Genomics | 1 | 2011 | 5722 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4216 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12035 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39045 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29784 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 19907 | 0.000 |
Why?
|